Silence Therapeutics (SLN) Other Non-Current Assets (2023 - 2026)

Silence Therapeutics has reported Other Non-Current Assets for 4 years, with the latest figure at $127000.0 in Q1 2026.

• Quarterly Other Non-Current Assets fell 96.49% year-over-year to $127000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127000.0 (down 96.49% YoY) and the FY2025 annual result came in at $127000.0, down 96.46% from the prior year.
• Other Non-Current Assets steadied at $127000.0 in Q1 2026 per SLN's latest filing, from $127000.0 in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $3.9 million in Q2 2025 and troughed at $127000.0 in Q4 2025.
• A 4-year average of $2.1 million and a median of $3.2 million in 2023 frame the typical range for Other Non-Current Assets.
• The sharpest annual moves came in 2024 and 2026: Other Non-Current Assets gained 12.11% in 2024, then plunged 96.49% in 2026.
• Over 4 years, Other Non-Current Assets stood at $3.2 million in 2023, then grew by 12.11% to $3.6 million in 2024, then sank by 96.46% to $127000.0 in 2025, then changed by 0.0% to $127000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $127000.0, $127000.0, and $399000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.